0 items USD 0.00Search
Your search for "mrrpb5 global united states european union china escitalopram market research report 2019 2025" gave back 128 results.
Claudin 6 (CLDN6) is a compelling tumor antigen. The tetraspan membrane protein is a member of the claudin family of tight junction proteins. CLDN6...
Catalog:
La Merie Publishing
May 2022
Price: USD 560.00
This report evaluates G-protein–coupled receptor family C group 5 member D (GPRC5D) from an industry perspective for its suitability as a tumor-...
Catalog:
La Merie Publishing
July 2022
Price: USD 670.00
This report evaluates Receptor tyrosine kinase-like Orphan Receptor 1 (ROR1) from an industry perspective for its suitability as a tumor-specific...
Catalog:
La Merie Publishing
June 2022
Price: USD 1,170.00
This report bundle includes four reports about novel cancer targets which have in common a compelling target expression profile with a low risk of on...
Catalog:
La Merie Publishing
July 2022
Price: USD 2,000.00
Cell analysis plays a major role in gene identification, protein identification, transcription analysis and epigenomics at cellular level. It proves...
Catalog:
IQ4I
April 2015
Price: USD 4,500.00
The global autoimmune disease diagnostics market was valued around US$ 14 Billion in 2021. Autoimmune diseases refer to a body's abnormal immune...
Catalog:
iGATE
June 2022
Price: USD 2,190.00
The global retinal surgery devices market is predicted to reach US$ 3.7 Billion by 2027. Retinal surgery device caters to a vast range of...
Catalog:
iGATE
August 2022
Price: USD 1,890.00
Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and...
Catalog:
La Merie Publishing
May 2020
Price: USD 2,350.00
Contract Research Organization Market Global Deals and Operational Strategies discusses the deal making activity during the past five years and in-...
Catalog:
CBR Pharma Insights
June 2015
Price: USD 2,995.00
Biosimilar and Biosuperior Therapeutic Antibodies 2014 The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic...
Catalog:
La Merie Publishing
March 2014
Price: USD 1,514.00
Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products...
Catalog:
CBR Pharma Insights
January 2018
Price: USD 2,995.00
Pharmaceutical Lifecycle Management Strategies in 2017 Summary GBI Research’s latest report, "Pharmaceutical Lifecycle Management Strategies in...
CBR Pharma Insights
April 2017
Price: USD 2,995.00
Market Reserach Reports, Inc is running a promotion until the end of April for a bundle of four antibody-related reports with a 50% discount on the...
Catalog:
La Merie Publishing
March 2014
Price: USD 4,766.00
Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline Summary GBI Research’s latest report, “Innovation...
CBR Pharma Insights
May 2017
Price: USD 2,995.00
A comparative analysis of the landscape of and business opportunities with TCR and CAR antibodies, T cells, NK cells, TILs, DLIs & CTLs The...
Catalog:
La Merie Publishing
March 2015
Price: USD 2,183.00
